At what ages is Adderall (amphetamine/dextroamphetamine) considered off‑label for its FDA‑approved indications such as ADHD and narcolepsy?

When Adderall Is Off-Label by Age

Adderall is off-label for ADHD in children under 3 years of age and for narcolepsy in children under 6 years of age. 1

FDA-Approved Age Ranges

According to the FDA drug label, Adderall (amphetamine/dextroamphetamine) has the following approved age indications:

• ADHD: Approved for children 3 to 17 years of age 1
• Narcolepsy: Approved for individuals 6 years and older 1

Off-Label Use Below Age 3 for ADHD

Any use of Adderall for ADHD in children younger than 3 years is off-label, as the FDA explicitly states "It is not known if Adderall is safe and effective in children with ADHD under 3 years of age." 1

Off-Label Use Below Age 6 for Narcolepsy

Similarly, Adderall use for narcolepsy in children under 6 years is off-label: "It is not known if Adderall is safe and effective in children with Narcolepsy under 6 years of age." 1

Clinical Context for Preschool-Aged Children (Ages 3-5)

While technically on-label for ADHD starting at age 3, the clinical guidelines reveal important nuances for ages 3-5 years:

• Dextroamphetamine (a component of Adderall) is the only stimulant with FDA approval for children under 6 years, but this approval was granted under less stringent historical criteria without adequate empirical evidence 2, 3
• Current AAP guidelines note that "the insufficient evidence for its safety and efficacy in this age group does not make it possible to recommend at this time" for preschool-aged children 2
• Methylphenidate is recommended over amphetamines as first-line pharmacologic treatment for preschool children ages 4-5 years, despite methylphenidate itself being off-label in this age group 3, 4

Practical Implications for Ages 3-5

For preschool children with ADHD:

1. Behavioral therapy should be first-line treatment 2
2. Medication should only be considered for moderate-to-severe dysfunction meeting these criteria:
   • Symptoms persisting ≥9 months
   • Dysfunction in both home and other settings (preschool/childcare)
   • Inadequate response to behavioral therapy 2, 3
3. If medication is needed, methylphenidate is preferred over Adderall despite both having limited evidence 3, 4

Off-Label Use in Very Young Children: The Evidence

Research confirms that off-label prescribing is extremely common in young children. Among children ages 3-5 years with ADHD, 91.4% of prescriptions were off-label, dropping to 21% after age 5 when more approved medications become available 5. This high rate reflects the gap between clinical need and regulatory approval.

No Upper Age Limit

There is no upper age limit where Adderall becomes off-label. The FDA approval extends through age 17 for ADHD, but this does not mean it becomes off-label at age 18—rather, adult use continues to be appropriate when clinically indicated, though the formal indication language focuses on the pediatric population for ADHD.